Learning objectives

After completing this module, participants should be able to:

  • Outline the mechanism of action, dose and side effects for each of the main classes of anti-diabetic drugs
  • Outline the rationale for use or contra-indications of these drugs in patients with cardiovascular disease (more details will be given in modules 3 and 4).
  • Discuss the use of each class of drugs in patients with chronic kidney disease


Dr Andrea Llano, Consultant Physician and Clinical Pharmacologist, Glasgow Royal Infirmary, Glasgow
Programme editor: Professor Miles Fisher, Honorary Professor, University of Glasgow, Glasgow


2 CPD/CME credits, 2 hours
BJC Learning has assigned 2 hours of CPD/CME credit to this module

You need to login to take this module

You need to be a registered member to view this page. It’s quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.

Source: bjcardio.co.uk

Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]